| 1. |
- Jonsson, Annikki, 1949, et al.
(författare)
-
Men's experience of their life situation when diagnosed with advanced prostate cancer.
- 2009
-
Ingår i: European journal of oncology nursing : the official journal of European Oncology Nursing Society. - : Elsevier BV. - 1532-2122 .- 1462-3889. ; 13:4, s. 268-73
-
Tidskriftsartikel (refereegranskat)abstract
- AIM: The aim was to improve the knowledge and understanding of how newly diagnosed advanced prostate cancer affects the men and their life situation and perhaps causes fatigue before the side effects of any treatment has an impact on them. METHOD: The qualitative study where ten men, newly diagnosed with advanced prostate cancer and at an early stage in their treatment, were interviewed. The interviews were analysed by using Gadamer's hermeneutics. RESULTS: The men in the present study did not experience fatigue specifically because they had been diagnosed for advanced prostate cancer. Three topics were identified during the analysis and interpretations: awareness of mortality, the influence on their emotions and the influence on their normal life. These topics offered a structure presenting the essence; the need to get back to as normal a life as possible, albeit with a new perspective. The topics together confirmed an affected life situation, which in turn helped the participants to form a new perspective on life. CONCLUSION: The knowledge and understanding of the study is that advanced prostate cancer affects men's lives: they are placed in a new life situation, against their will, and in their new situation they form a new life perspective. Healthcare professionals need to evaluate, perceive and furthermore understand the men's apprehensions and expectations, on an individual basis, for their future and empower them to formulate a new life perspective.
|
|
| 2. |
|
|
| 3. |
- Schröder, Fritz H, et al.
(författare)
-
Screening and prostate-cancer mortality in a randomized European study.
- 2009
-
Ingår i: The New England journal of medicine. - 1533-4406 .- 0028-4793. ; 360:13, s. 1320-8
-
Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)abstract
- The European Randomized Study of Screening for Prostate Cancer was initiated in the early 1990s to evaluate the effect of screening with prostate-specific-antigen (PSA) testing on death rates from prostate cancer.
|
|
| 4. |
|
|
| 5. |
- Jonsson, Annikki, 1949, et al.
(författare)
-
Living with a prostate cancer diagnosis: a qualitative 2-year follow-up.
- 2010
-
Ingår i: AGING MALE. - : Informa UK Limited. - 1368-5538 .- 1473-0790. ; 13:1, s. 25-31
-
Tidskriftsartikel (refereegranskat)abstract
- Aim. Previous research has identified how newly diagnosed prostate cancer affects men's daily lives, including daily activities and existential issues. The aim of this qualitative study was to provide information if and how prostate cancer affects men's daily lives 2 years after the diagnosis. Methods. A second follow-up interview with men who were diagnosed with localized or advanced prostate cancer approximately 18-24 months earlier. Twenty-two men aged 50-85 years participated, data were analyzed by hermeneutical interpretation with Gadamer's approach. Results. The men feel healthy, but prostate cancer affects their daily lives. They experience every day fatigue associated with several changes in life due to age. Three equivalent fusions which influenced the men are: 'Age is claiming its due', 'Living with uncertainty', and 'Strengthen self-esteem'. The unifying fusion is identified as 'Balancing a changed life situation.' Conclusions. There is need for knowledge and guidance for men with prostate cancer on how to adapt to new life situation decreasing uncertainty and increasing welfare. Men found a sense of pride, despite physical changes, in appreciating independence and close relationships. Value of life was readjusted. The findings indicate harmony in living, enjoying being frank as well as rating the 'little' things.
|
|
| 6. |
- Jonsson, Annikki, 1949, et al.
(författare)
-
Men's perception of fatigue when newly diagnosed with localized prostate cancer.
- 2007
-
Ingår i: Scand J Urol Nephrol. - : Informa UK Limited. ; 41:1, s. 20-25
-
Tidskriftsartikel (refereegranskat)abstract
- Objectives. Cancer is a complicated issue both medically and psychosocially, and the process of the disease affects the whole human being. Fatigue is the commonest symptom associated with cancer and its treatment. Prostate cancer is the third commonest male cancer worldwide and the leading cause of male cancer death. The aims of this study were: (i) to identify whether fatigue is found in men with newly diagnosed localized prostate cancer (predominantly early-stage, very low tumour burden asymptomatic patients); and (ii) to gain a perception of whether fatigue has an influence on these men and to try to find out what the cause of this fatigue was. Material and methods. Sixteen men who had been newly diagnosed with localized prostate cancer were interviewed to determine whether fatigue is experienced by such men and whether it has an effect on them. Verbal transcripts were analyzed using hermeneutical interpretation. Results. Five equivalent fusions were identified according to the time when the participants received their diagnosis of early-stage prostate cancer. These fusions occurred successively, in three steps. The first step was Enclosing Intrapersonal Emotions and Enclosing Interpersonal Attachments, when the men were living in a kind of vacuum. Moving onto step two, another two fusions were triggered and contributed to a positive attitude: Reopening Intrapersonal Emotions and Reopening Interpersonal Attachments. Finally, at step three, a unifying fusion was identified: Living with a New Perspective. This study provides insights and new knowledge indicating that prostate cancer does not in itself cause fatigue. Conclusions. The clinical implications of these findings are that it is not possible to handle new and detailed information about prostate cancer at the first visit. The need for information occurs, however, relatively soon afterwards and it would seem appropriate to offer a new appointment within 1 week of the first visit.
|
|
| 7. |
- Schelin, Sonny, et al.
(författare)
-
Long-term follow-up after triple treatment of prostate cancer stage pT3.
- 2009
-
Ingår i: Scandinavian journal of urology and nephrology. - : Informa UK Limited. - 0036-5599 .- 1651-2065. ; 43:3, s. 186-91
-
Tidskriftsartikel (refereegranskat)abstract
- OBJECTIVE: Radical prostatectomy (RP) has become the most common treatment for localized prostate cancer in Sweden. Outcome is extremely good for pT2 stage with Gleason score 6 or less, but more than every fourth operated patient will have a pT3 stage on full amount specimen histology. According to several reports the risk of biochemical recurrence is quite high, especially in stage pT3, on active surveillance after surgery alone. In 1994 the authors recognized this fact at their clinic and decided to apply a new multimodality treatment concept. MATERIAL AND METHODS: During 10 years, between 1 January 1995 and 1 January 2005, 98 pT3 patients were treated with a triple treatment: 8 months of neoadjuvant/adjuvant luteinizing hormone-releasing hormone (LH-RH) analogue treatment, RP and immediate adjuvant radiotherapy (RT) 3 months after RP. RT was delivered to 60 Gy in 30 fractions to the prostatic bed to all the patients. The cumulative risk of progression was calculated with the Kaplan-Meier method. The impact of risk factors was evaluated by the Cox proportional hazard model. RESULTS: Ninety-eight (74 pT3a and 24 pT3b) patients were followed with a mean observation time from operation until October 2007 of 71.6 (median 65.5, range 35-146) months. The mean follow-up time to biochemical failure, death or last measurement of prostate-specific antigen (PSA) was 57.8 (median 57.0, range 3-132) months. Fifteen patients out of 98 had experienced biochemical failure. Only Gleason score had an independent impact on the risk of PSA progression. Complications were mild and temporary and no serious adverse events were registered. CONCLUSIONS: Patients with locally advanced prostate cancer have a high risk of progression after RP as single therapy. Postoperative RT has been shown to improve the outcome. Neoadjuvant/adjuvant hormonal therapy has been shown to improve the outcome after RT. Bringing this knowledge together offering a multimodality therapy with neoadjuvant/adjuvant hormonal therapy, RP followed by postoperative immediate RT seems to offer a high chance of biochemical-free survival.
|
|
| 8. |
|
|
| 9. |
|
|
| 10. |
|
|
